FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3217233314> ?p ?o ?g. }

• W3217233314 endingPage "320" @default.
• W3217233314 startingPage "309" @default.
• W3217233314 abstract "Repaglinide, a member of the meglitinide class of drugs, is a new anti-diabetic agent that is utilized as an oral hypoglycemic agent. Using glyceryl monostearate, cetyl palmitate, and tristearin as lipids and poloxamer 188 as a surfactant, repaglinide-loaded solid lipid nanoparticles were created. Solid lipid nanoparticles were prepared utilizing an o/w microemulsion technique, which included the lipids glyceryl monostearate and tristearin, as well as waxes such as cetyl palmitate and the surfactant poloxamer 188. The mean particle size of the solid lipid nanoparticles formed was around 339 nm, with an entrapment efficiency of 82.20%. In-vitro release studies continued to be conducted using the dialysis bag diffusion technique. Within 12 h, the cumulative drug release was 88.4%. The results indicate that repaglinide was released more slowly from solid lipid nanoparticles made from tristearin and glyceryl monostearate in an equal ratio. Tristearin found the controlled release and extreme entrapment from other lipid carriers like glyceryl monostearate and cetyl palmitate. Differential scanning calorimetry demonstrates that repaglinide is entangled in amorphous or molecular state within solid lipid nanoparticles. SEM microscopy revealed that the produced repaglinide solid lipid nanoparticles had a spherical shape. After one month of storage at 2-8 °C, short-term stability testing revealed no significant alteration." @default.
• W3217233314 created "2021-12-06" @default.
• W3217233314 creator A5001714683 @default.
• W3217233314 creator A5022803174 @default.
• W3217233314 creator A5037780530 @default.
• W3217233314 creator A5049916581 @default.
• W3217233314 creator A5068986887 @default.
• W3217233314 date "2021-11-23" @default.
• W3217233314 modified "2023-10-16" @default.
• W3217233314 title "Design expert assisted formulation, characterization and optimization of microemulsion based solid lipid nanoparticles of repaglinide" @default.
• W3217233314 cites W1553373140 @default.
• W3217233314 cites W1579046626 @default.
• W3217233314 cites W1930709060 @default.
• W3217233314 cites W1981468523 @default.
• W3217233314 cites W2019395934 @default.
• W3217233314 cites W2044903986 @default.
• W3217233314 cites W2051102050 @default.
• W3217233314 cites W2052389363 @default.
• W3217233314 cites W2071631289 @default.
• W3217233314 cites W2102126716 @default.
• W3217233314 cites W2169946060 @default.
• W3217233314 cites W2175882543 @default.
• W3217233314 cites W2300123552 @default.
• W3217233314 cites W2326507095 @default.
• W3217233314 cites W2330882647 @default.
• W3217233314 cites W3014534615 @default.
• W3217233314 cites W3102817115 @default.
• W3217233314 cites W3107605542 @default.
• W3217233314 doi "https://doi.org/10.1007/s40204-021-00174-3" @default.
• W3217233314 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34813041" @default.
• W3217233314 hasPublicationYear "2021" @default.
• W3217233314 type Work @default.
• W3217233314 sameAs 3217233314 @default.
• W3217233314 citedByCount "7" @default.
• W3217233314 countsByYear W32172333142022 @default.
• W3217233314 countsByYear W32172333142023 @default.
• W3217233314 crossrefType "journal-article" @default.
• W3217233314 hasAuthorship W3217233314A5001714683 @default.
• W3217233314 hasAuthorship W3217233314A5022803174 @default.
• W3217233314 hasAuthorship W3217233314A5037780530 @default.
• W3217233314 hasAuthorship W3217233314A5049916581 @default.
• W3217233314 hasAuthorship W3217233314A5068986887 @default.
• W3217233314 hasBestOaLocation W32172333142 @default.
• W3217233314 hasConcept C101335993 @default.
• W3217233314 hasConcept C121332964 @default.
• W3217233314 hasConcept C127413603 @default.
• W3217233314 hasConcept C134018914 @default.
• W3217233314 hasConcept C147789679 @default.
• W3217233314 hasConcept C155672457 @default.
• W3217233314 hasConcept C15920480 @default.
• W3217233314 hasConcept C171250308 @default.
• W3217233314 hasConcept C178790620 @default.
• W3217233314 hasConcept C185592680 @default.
• W3217233314 hasConcept C187530423 @default.
• W3217233314 hasConcept C190119865 @default.
• W3217233314 hasConcept C192562407 @default.
• W3217233314 hasConcept C199529486 @default.
• W3217233314 hasConcept C2779306644 @default.
• W3217233314 hasConcept C2779516699 @default.
• W3217233314 hasConcept C2780323712 @default.
• W3217233314 hasConcept C2781281211 @default.
• W3217233314 hasConcept C39519442 @default.
• W3217233314 hasConcept C42360764 @default.
• W3217233314 hasConcept C43617362 @default.
• W3217233314 hasConcept C521977710 @default.
• W3217233314 hasConcept C55493867 @default.
• W3217233314 hasConcept C58226133 @default.
• W3217233314 hasConcept C71924100 @default.
• W3217233314 hasConcept C86181022 @default.
• W3217233314 hasConcept C97355855 @default.
• W3217233314 hasConceptScore W3217233314C101335993 @default.
• W3217233314 hasConceptScore W3217233314C121332964 @default.
• W3217233314 hasConceptScore W3217233314C127413603 @default.
• W3217233314 hasConceptScore W3217233314C134018914 @default.
• W3217233314 hasConceptScore W3217233314C147789679 @default.
• W3217233314 hasConceptScore W3217233314C155672457 @default.
• W3217233314 hasConceptScore W3217233314C15920480 @default.
• W3217233314 hasConceptScore W3217233314C171250308 @default.
• W3217233314 hasConceptScore W3217233314C178790620 @default.
• W3217233314 hasConceptScore W3217233314C185592680 @default.
• W3217233314 hasConceptScore W3217233314C187530423 @default.
• W3217233314 hasConceptScore W3217233314C190119865 @default.
• W3217233314 hasConceptScore W3217233314C192562407 @default.
• W3217233314 hasConceptScore W3217233314C199529486 @default.
• W3217233314 hasConceptScore W3217233314C2779306644 @default.
• W3217233314 hasConceptScore W3217233314C2779516699 @default.
• W3217233314 hasConceptScore W3217233314C2780323712 @default.
• W3217233314 hasConceptScore W3217233314C2781281211 @default.
• W3217233314 hasConceptScore W3217233314C39519442 @default.
• W3217233314 hasConceptScore W3217233314C42360764 @default.
• W3217233314 hasConceptScore W3217233314C43617362 @default.
• W3217233314 hasConceptScore W3217233314C521977710 @default.
• W3217233314 hasConceptScore W3217233314C55493867 @default.
• W3217233314 hasConceptScore W3217233314C58226133 @default.
• W3217233314 hasConceptScore W3217233314C71924100 @default.
• W3217233314 hasConceptScore W3217233314C86181022 @default.
• W3217233314 hasConceptScore W3217233314C97355855 @default.
• W3217233314 hasIssue "4" @default.

• next